PMC:7340597 / 3386-3654 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T7","span":{"begin":37,"end":45},"obj":"Body_part"}],"attributes":[{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma264783"}],"text":"ta in COVID-19 patients show diffuse alveolar damage, closely related to ARDS [[10], [11], [12]]. The clinical relevance of COVID-19-associated pulmonary aspergillosis (CAPA) as well as survival benefit with antifungal treatment and associated mortality are under deba"}

{"project":"LitCovid-PubTator","denotations":[{"id":"124","span":{"begin":15,"end":23},"obj":"Species"},{"id":"143","span":{"begin":6,"end":14},"obj":"Disease"},{"id":"144","span":{"begin":37,"end":52},"obj":"Disease"},{"id":"145","span":{"begin":73,"end":77},"obj":"Disease"},{"id":"146","span":{"begin":124,"end":132},"obj":"Disease"},{"id":"147","span":{"begin":144,"end":167},"obj":"Disease"},{"id":"148","span":{"begin":244,"end":253},"obj":"Disease"}],"attributes":[{"id":"A124","pred":"tao:has_database_id","subj":"124","obj":"Tax:9606"},{"id":"A143","pred":"tao:has_database_id","subj":"143","obj":"MESH:C000657245"},{"id":"A144","pred":"tao:has_database_id","subj":"144","obj":"MESH:D055370"},{"id":"A145","pred":"tao:has_database_id","subj":"145","obj":"MESH:D012128"},{"id":"A146","pred":"tao:has_database_id","subj":"146","obj":"MESH:C000657245"},{"id":"A147","pred":"tao:has_database_id","subj":"147","obj":"MESH:D055732"},{"id":"A148","pred":"tao:has_database_id","subj":"148","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ta in COVID-19 patients show diffuse alveolar damage, closely related to ARDS [[10], [11], [12]]. The clinical relevance of COVID-19-associated pulmonary aspergillosis (CAPA) as well as survival benefit with antifungal treatment and associated mortality are under deba"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T52","span":{"begin":6,"end":14},"obj":"Disease"},{"id":"T53","span":{"begin":73,"end":77},"obj":"Disease"},{"id":"T54","span":{"begin":124,"end":132},"obj":"Disease"},{"id":"T55","span":{"begin":154,"end":167},"obj":"Disease"},{"id":"T56","span":{"begin":169,"end":173},"obj":"Disease"}],"attributes":[{"id":"A52","pred":"mondo_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A53","pred":"mondo_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A54","pred":"mondo_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A55","pred":"mondo_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A56","pred":"mondo_id","subj":"T56","obj":"http://purl.obolibrary.org/obo/MONDO_0007163"}],"text":"ta in COVID-19 patients show diffuse alveolar damage, closely related to ARDS [[10], [11], [12]]. The clinical relevance of COVID-19-associated pulmonary aspergillosis (CAPA) as well as survival benefit with antifungal treatment and associated mortality are under deba"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T20","span":{"begin":86,"end":88},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"}],"text":"ta in COVID-19 patients show diffuse alveolar damage, closely related to ARDS [[10], [11], [12]]. The clinical relevance of COVID-19-associated pulmonary aspergillosis (CAPA) as well as survival benefit with antifungal treatment and associated mortality are under deba"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T2","span":{"begin":208,"end":218},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_35718"}],"text":"ta in COVID-19 patients show diffuse alveolar damage, closely related to ARDS [[10], [11], [12]]. The clinical relevance of COVID-19-associated pulmonary aspergillosis (CAPA) as well as survival benefit with antifungal treatment and associated mortality are under deba"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T11","span":{"begin":29,"end":52},"obj":"Phenotype"}],"attributes":[{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0033006"}],"text":"ta in COVID-19 patients show diffuse alveolar damage, closely related to ARDS [[10], [11], [12]]. The clinical relevance of COVID-19-associated pulmonary aspergillosis (CAPA) as well as survival benefit with antifungal treatment and associated mortality are under deba"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T44","span":{"begin":6,"end":14},"obj":"SP_7"},{"id":"T45","span":{"begin":37,"end":45},"obj":"UBERON:0003215"},{"id":"T46","span":{"begin":124,"end":132},"obj":"SP_7"},{"id":"T47","span":{"begin":144,"end":153},"obj":"UBERON:0002048"},{"id":"T86981","span":{"begin":14,"end":29},"obj":"UBERON:0002031"},{"id":"T51837","span":{"begin":30,"end":36},"obj":"UBERON:0004821"},{"id":"T19506","span":{"begin":70,"end":77},"obj":"CHEBI:59132;CHEBI:59132"},{"id":"T9649","span":{"begin":156,"end":165},"obj":"UBERON:0002048"}],"text":"ta in COVID-19 patients show diffuse alveolar damage, closely related to ARDS [[10], [11], [12]]. The clinical relevance of COVID-19-associated pulmonary aspergillosis (CAPA) as well as survival benefit with antifungal treatment and associated mortality are under deba"}